Mitsubishi UFJ Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.3K | Buy |
+586
| New | +$25.3K | ﹤0.01% | 1128 |
|
2024
Q2 | – | Sell |
-5,845
| Closed | -$181K | – | 1574 |
|
2024
Q1 | $181K | Sell |
5,845
-268
| -4% | -$8.29K | ﹤0.01% | 970 |
|
2023
Q4 | $231K | Sell |
6,113
-9,176
| -60% | -$347K | ﹤0.01% | 994 |
|
2023
Q3 | $403K | Buy |
15,289
+720
| +5% | +$19K | ﹤0.01% | 949 |
|
2023
Q2 | $251K | Sell |
14,569
-6,474
| -31% | -$111K | ﹤0.01% | 1009 |
|
2023
Q1 | $349K | Buy |
21,043
+1,699
| +9% | +$28.2K | ﹤0.01% | 968 |
|
2022
Q4 | $139K | Sell |
19,344
-5,534
| -22% | -$39.7K | ﹤0.01% | 1061 |
|
2022
Q3 | $247K | Buy |
24,878
+1,613
| +7% | +$16K | ﹤0.01% | 1001 |
|
2022
Q2 | $211K | Buy |
+23,265
| New | +$211K | ﹤0.01% | 1038 |
|